|
|
||||||||
From the Division of Maternal-Fetal Medicine, Department of Obstetrics and Gynecology, University of Southern California School of Medicine and Women's Hospital, Los Angeles County/University of Southern California Medical Center, Los Angeles, California
Abstract
A prospective randomized study of 85 parturients was undertaken comparing the safety and efficacy of a 3-mg prostaglandin E2 vaginal suppository with intravenous oxytocin for the induction of labor. All patients were required to have a Bishop's score of 5 or higher. Labor was successfully induced in 98% of the patients in both groups by their respective methods. Sixty-four percent of the patients receiving a 3-mg prostaglandin E2 suppository required no intravenous oxytocin. More specifically, 82% (23/28) of the parous patients but only 29% (5/17) of the nulliparous patients who received a single 3-mg prostaglandin E2 suppository for labor induction did not require oxytocin augmentation (P<.005). The first and second stages of labor were not significantly different for the two groups, and there was no significant difference in the incidence of cesarean section. A 3-mg prostaglandin E2 vaginal suppository may be a useful alternative to oxytocin for the induction of labor in carefully selected patients.
This article has been cited by other articles:
![]() |
L. Sanchez-Ramos, A. M. Kaunitz, I. Delke, and F. L. Gaudier CERVICAL RIPENING AND LABOR INDUCTION WITH A CONTROLLED-RELEASE DINOPROSTONE VAGINAL INSERT: A META-ANALYSIS Obstet. Gynecol., November 1, 1999; 94(5): 878 - 883. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |